Asthma inhalers tied to large greenhouse gas emissions production
By
Haymarket Media
Sep 04, 2024
Metered-dose inhalers were responsible for almost all inhaler-related emissions.
Review shows certain exercises benefit patients with asthma
Aug 14, 2023
Yoga, breathing control practices and aerobic training show benefits.
Traffic-related air pollution may impact women more
Sep 20, 2022
The effects on plasma proteins known to play a role in inflammation, oxidative stress and cardiovascular disease are greater in women than in men.
Less than 1 percent of COVID-19 patients experience reinfection
Jun 28, 2021
Symptoms of severe disease are less frequent with reinfection, although death can occur.
FDA-cleared wearables are the future of senior care
By
Jiang Li
Jan 10, 2019
Greater access to proven remote patient monitoring technologies can lead to safer and more effective healthcare among older adults while also reducing the cost and burden incurred through senior care.
Dry powder inhalers show benefits for asthma control, environment
Feb 08, 2022
Switching to a dry powder inhaler more than halves the carbon footprint of asthma treatment without asthma worsening.
Tezepelumab reduces mucus plugs in adults with uncontrolled asthma
Sep 29, 2023
The reduction in mucus plug scores correlates with improvements in lung function and reductions in inflammatory markers.
Itepekimab bests placebo for moderate-to-severe asthma
Oct 28, 2021
The incidence of events indicating a loss of asthma control was lower with itepekimab monotherapy in a phase 2, proof-of-concept trial.
Environmental Protection Agency finalizes stronger air quality standards
Feb 09, 2024
The agency estimates that the new standard will prevent up to 4,500 premature deaths in the first year of full enforcement.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.